Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · DBV Technologies S.A. (DBVT)

DBV Technologies Q2 net loss widens to $50.4 million; BLA filing slips to Q3 2026

Negative Impact 4 of 5 earnings Written later

DBV Technologies reported a second-quarter 2026 net loss of $50.4 million, up from $41.9 million a year earlier, with six-month losses of $98.0 million versus $69.0 million. The company said it now expects to submit its BLA for the VIASKIN Peanut Patch in the third quarter of 2026, and it reported $174.9 million in cash, funding operations into the third quarter of 2027.

Key points

  • Q2 2026 net loss was $50.4 million, up from $41.9 million in Q2 2025; six-month net loss was $98.0 million versus $69.0 million.
  • Six-month R&D expenses rose to $64.6 million from $55.2 million, and SG&A rose by $20.7 million, as the company prepares for a potential U.S. launch.
  • Cash and cash equivalents were $174.9 million as of June 30, 2026, funding operations into the third quarter of 2027.
  • BLA submission for VIASKIN Peanut Patch in children aged 4 through 7 is now anticipated in the third quarter of 2026, after the prior timing of the second quarter.

The filing

CompanyDBV Technologies S.A. (DBVT)
Form8-K, current report
Filed with the SECJul 16, 2026, 5:02 PM ET
Accession number0001193125-26-306222

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 16, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.